BioLargo Subsidiary Clyra Medical’s Clyraguard Product Shows Complete Inactivation of SARS-CoV-2 Virus in Galveston National Lab Study

Press/Media: Expert Comment

PeriodMay 19 2020 → May 21 2020

Media coverage

5

Media coverage

Keywords

  • COVID-19